GETTING STARTED
Setting your patients up for success
-
Set realistic expectations
- As the patient titrates, they may not see immediate clinical improvements2,3
Explain importance of titrating to realize full benefits4
-
Prepare for common AEs
- Review AEs (eg, cough, headache, and throat irritation) and why they may occur5
- Give patients specific instructions to proactively manage any AEs that occur
- Complete AE Management section on the Referral Form
Stress that they should not stop treatment without consulting you
-
Ensure patients understand the dosing plan
- TYVASO DPI can be titrated by starting with 16 mcg (1 cartridge) 4x daily and increasing by 16 mcg every 1-2 weeks6
- TYVASO can be titrated by starting with 3 breaths per treatment session and increasing by 3 breaths every 1-2 weeks2
- There is no maximum labeled dose with TYVASO or TYVASO DPI2,6
- Once reaching their maintenance dose, the patient should maintain that dose with each treatment session2,6
Emphasize the importance of completing all 4 daily treatment sessions
You can help patients understand what to expect by walking them through the Referral Form.
AE=adverse event; DPI=dry powder inhaler.
The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE to return to the consumer section of the site.